imiquimod has been researched along with Inflammatory Bowel Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, KS; Hung, IF; Ko, KL; Lam, YF; Leung, WK | 1 |
| Daien, CI; King, NJC; Macia, L; Mielle, J; Moore, RJ; Ni, D; Pinget, GV; Simpson, S; Stanley, D; Taitz, J; Tan, JK | 1 |
| Chen, X; Cheng, L; Dai, L; Deng, H; Deng, J; Li, Y; Lin, Y; Mao, Y; Shi, G; Su, X; Wang, Y; Wei, Y; Yang, Y; Yu, D; Zhang, J; Zhang, S; Zhang, X; Zhang, Y | 1 |
1 trial(s) available for imiquimod and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Clinical trial: intra dermal hepatitis B vaccination with topical imiquimod versus intra muscular hepatitis B vaccination in patients with inflammatory bowel disease.
Topics: Adult; Chronic Disease; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Imiquimod; Inflammatory Bowel Diseases; Injections, Intradermal; Injections, Intramuscular; Male; Vaccination | 2022 |
2 other study(ies) available for imiquimod and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Dysbiosis in imiquimod-induced psoriasis alters gut immunity and exacerbates colitis development.
Topics: Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Dysbiosis; Imiquimod; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Psoriasis | 2022 |
IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells.
Topics: Acute Disease; Animals; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Female; Humans; Imiquimod; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukins; Lymphocytes; Macrophages; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Phenotype; Psoriasis; Recombinant Proteins; T-Lymphocytes; Vascular Endothelial Growth Factor A | 2018 |